MedTrace Logo

Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack

NCT00931788 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 279

Last updated 2018-10-15

No results posted yet for this study

Summary

People who have had a stroke or transient ischemic attack (TIA or "mini-stroke") are at high risk of having another stroke or a heart attack. Conditions like high blood pressure and high cholesterol, along with other lifestyle behaviors (e.g., smoking), substantially increase the risk of stroke and heart disease. Aggressive treatment of these risk factors however, can significantly reduce the chance of another stroke, heart attack or death.

This study will look at different ways to optimize blood pressure and cholesterol levels and educate people about positive lifestyle changes.

Conditions

Interventions

DRUG

Antihypertensive agents and lipid lowering therapy

The above agents will be initiated/titrated in accordance to guidelines approved by Canadian Hypertension Education Program and the Canadian Best Practice Recommendations for Stroke Care

OTHER

Usual Care

Monthly education and reinforcement of risk factor modification, and blood pressure measurement.

Sponsors & Collaborators

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • Alberta Heritage Foundation for Medical Research

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Finlay A McAlister, MD, MSc · Department of Medicine, University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-05-31
Completion
2013-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00931788 on ClinicalTrials.gov